Tag: Pharmaceuticals
Business & Industry
CytomX and Regeneron Expand Bispecific Cancer Therapy Collaboration with New Targets
CytomX Therapeutics and Regeneron Pharmaceuticals have expanded their ongoing research collaboration focused on developing tumor-activated bispecific cancer therapy candidates, broadening the scope of an...
Business & Industry
Eli Lilly Genetic Medicine Push Expands with Ascidian Deal
Eli Lilly has entered into a research collaboration with Ascidian Therapeutics aimed at discovering and developing treatments for kidney diseases, marking another step in...
Business & Industry
Aragen Backs Renaissance Rare Disease Therapy Launch
Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead...
Business & Industry
Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi
Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is...
Business & Industry
Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement
The Pfizer Innovent Cancer Deal has been finalized, establishing a global licensing and collaboration agreement valued at up to $10.5 billion. The transaction focuses...
BioPharma
Nestlé and IdB Partner to Bring rCDI Preventive Therapy to Europe
Nestlé Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to...
Business & Industry
CordenPharma Seals AmbioPharm Deal to Expand Global Network
CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read